Categories: News

Cheelcare Turns Heads at the Canadian Seating and Mobility Conference in Toronto

Toronto, Ontario–(Newsfile Corp. – September 11, 2025) – Cheelcare Inc. (TSXV: CHER) (“Cheelcare” or the “Company”), a Canadian leader in assistive mobility devices, turned heads at the 2025 Canadian Seating and Mobility Conference (CSMC), one of Canada’s premier gatherings for rehabilitation professionals, clinicians, and mobility industry leaders.

Providers try Curio at Cheelcare’s booth at the 2025 CSMC

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11847/265899_csmc1.jpg

Cheelcare presented its latest updates to the Companion power-assist system alongside the company’s newest innovation, Curio – Cheelcare’s complex rehab power wheelchair built on their patented robotic platform. Both devices are designed to provide wheelchair users with enhanced quality of life and independence.

Cheelcare’s Sales Representative for Ontario Demonstrates Newest Companion Product Updates at 2025 CSMC

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11847/265899_csmc2.jpg

“CSMC is Canada’s largest event for our industry and allows us to directly connect with the clinicians, providers, and assistive technology professionals who are on the front lines of mobility care,” said Allan Boyd, Cheelcare’s VP of Growth. “The response to both Companion and Curio has been very positive and highlights the demand for more innovative solutions in the mobility market.”

About Cheelcare Inc.
Cheelcare designs and manufactures innovative mobility solutions that empower independence for people with disabilities. From the Companion power assist devices to the groundbreaking Curio robotic wheelchair, Cheelcare combines engineering excellence with human-centered design to improve quality of life.

For more information, please visit: www.cheelcare.ca.

For further information, please contact:
Allex Laurin, Director of Marketing
Cheelcare Inc.
Tel: 1-888-948-2680 x200
Email: alaurin@cheelcare.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265899

Staff

Recent Posts

Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship

The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…

2 hours ago

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…

2 hours ago

KLAS Report Shows Strong Early Results for TrustCommerce Cloud Payments

CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…

2 hours ago

BioFlorida Announces Appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of the Southeast Chapter

MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…

2 hours ago

Truemed Closes $34 Million Series A To Unlock HSA/FSA Funds For Lifestyle Interventions

Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…

2 hours ago

Trump’s Marijuana Schedule III Order Launches a Federally Regulated Healthcare Sector

MMJ's position is further fortified by its FDA Orphan Drug Designations for the treatment of…

2 hours ago